Pharmaceutical Portfolio Management: Global Disease Burden and Corporate Performance Metrics

Projections of Global Mortality and Burden of Disease from 2002 to 2030

Colin Mathers, Dejan Lončar · PLoS Medicine · 2006 · 11.5K citations · Full text

Public Health, Health Policy, Epidemiology +16

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

Christopher J L Murray, Theo Vos, Rafael Lozano et al. · The Lancet · 2012 · 9K citations

Public Health, Health Sciences, Public Health Practice +17

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

Christopher J L Murray, Alan D López · The Lancet · 1997 · 7K citations

Public Health, Health Sciences, Population Health Sciences +17

The price of innovation: new estimates of drug development costs

Joseph A. DiMasi, Ronald W. Hansen, Henry G. Grabowski · Journal of Health Economics · 2003 · 4.3K citations · Full text

Pharmacy, Pharmaceutical Policy, Pharmacoeconomics +14

Quantifying the burden of disease: the technical basis for disability-adjusted life years.

Chris Murray · PubMed · 1994 · 1.6K citations

Public Health, Geriatric Medicine, Geriatric Assessment +16